The risk of infection with new oral anticoagulants: a meta-analysis.
Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal; Laboratory of Clinical Pharmacology, Faculty of Medicine, University of Lisbon, Portugal. Electronic address: dgcaldeira@hotmail.com.
Daniel
D
Caldeira
Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal; Laboratory of Clinical Pharmacology, Faculty of Medicine, University of Lisbon, Portugal; Portuguese Collaborating Centre of the Cochrane Iberoamerican Network, Faculty of Medicine, University of Lisbon, Portugal.
João
J
Costa
Cardiology Department, CCUL, CAML, Faculty of Medicine, Lisbon, Portugal.
Fausto J
FJ
Pinto
Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal; Laboratory of Clinical Pharmacology, Faculty of Medicine, University of Lisbon, Portugal.
Joaquim J
JJ
Ferreira
D000925:Anticoagulants / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009025:Morpholines / Q000009:adverse effects*; D018805:Sepsis / Q000175:diagnosis*; D020521:Stroke / Q000175:diagnosis*; D013876:Thiophenes / Q000009:adverse effects*; D014552:Urinary Tract Infections / Q000175:diagnosis*
D000925:Anticoagulants; D009025:Morpholines; D013876:Thiophenes
Apixaban; Dabigatran; Infection; Meta-analysis; Rivaroxaban; Urinary tract infection